Patents by Inventor Burt G. Feuerstein

Burt G. Feuerstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSING IDH1 RELATED SUBGROUPS AND TREATMENT OF CANCER
    Publication number: 20200340066
    Abstract: The invention relates to classification, diagnosis and treatment of cancers. In one embodiment, the present invention provides methods and kits that classify cancers into various subtypes based on expression patterns of AKT pathway components. In another embodiment, the present invention provides methods and kits that diagnose cancer subtypes by evaluating expression patterns of AKT pathway components. In still another embodiment, the present invention provides methods and kits that treat a cancer subtype by administering an alkylating agent or a PI3K/AKT/mTOR inhibitor to a patient. Cancers suitable with various embodiments of the invention include but are not limited to brain tumors, gliomas and GBM.
    Type: Application
    Filed: July 8, 2020
    Publication date: October 29, 2020
    Applicant: Dignity Health
    Inventors: Anna Joy, Burt G. Feuerstein, Ivan Smirnov
  • Diagnosing IDH1 related subgroups and treatment of cancer
    Patent number: 10731221
    Abstract: The invention relates to classification, diagnosis and treatment of cancers. In one embodiment, the present invention provides methods and kits that classify cancers into various subtypes based on expression patterns of AKT pathway components. In another embodiment, the present invention provides methods and kits that diagnose cancer subtypes by evaluating expression patterns of AKT pathway components. In still another embodiment, the present invention provides methods and kits that treat a cancer subtype by administering an alkylating agent or a PI3K/AKT/mTOR inhibitor to a patient. Cancers suitable with various embodiments of the invention include but are not limited to brain tumors, gliomas and GBM.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: August 4, 2020
    Assignee: Dignity Health
    Inventors: Anna Joy, Burt G. Feuerstein, Ivan Smirnov
  • DIAGNOSING IDH1 RELATED SUBGROUPS AND TREATMENT OF CANCER
    Publication number: 20150354012
    Abstract: The invention relates to classification, diagnosis and treatment of cancers. In one embodiment, the present invention provides methods and kits that classify cancers into various subtypes based on expression patterns of AKT pathway components. In another embodiment, the present invention provides methods and kits that diagnose cancer subtypes by evaluating expression patterns of AKT pathway components. In still another embodiment, the present invention provides methods and kits that treat a cancer subtype by administering an alkylating agent or a PI3K/AKT/mTOR inhibitor to a patient. Cancers suitable with various embodiments of the invention include but are not limited to brain tumors, gliomas and GBM.
    Type: Application
    Filed: August 14, 2015
    Publication date: December 10, 2015
    Applicant: DIGNITY HEALTH
    Inventors: Anna Joy, Burt G. Feuerstein, Ivan Smirnov
  • PI3K/AKT PATHWAY SUBGROUPS IN CANCER: METHODS OF USING BIOMARKERS FOR DIAGNOSIS AND THERAPY
    Publication number: 20120252856
    Abstract: The present invention relates to methods of dividing cancer into subgroups based upon Akt pathway gene expression. In one embodiment, the present invention provides a method of diagnosing glioblastoma multiforme (GBM) subtype in an individual by determining the presence of an abnormal expression of an Akt pathway gene cluster and diagnosing the cancer subtype in the individual.
    Type: Application
    Filed: December 10, 2010
    Publication date: October 4, 2012
    Applicant: Dignity Health
    Inventors: Anna Joy, Burt G. Feuerstein, Ivan Smimov
  • Glioma-associated nucleic acid probes
    Patent number: 5994529
    Abstract: The present invention provides chromosomal amplifications and deletions associated with neoplastic growth of gliomas. These amplifications and deletions may be used for detecting and grading gliomas. The invention also provides compositions for the detection of gliomas.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: November 30, 1999
    Assignee: The Regents of the University of California
    Inventors: Burt G. Feuerstein, Gayatry Mohapatra, Dong Hyung Kim
  • Genetic gain and loss in gliomas
    Patent number: 5635351
    Abstract: The present invention provides chromosomal amplifications and deletions associated with neoplastic growth of gliomas. These amplifications and deletions may be used for detecting and grading gliomas. The invention also provides compositions for the detection of gliomas.
    Type: Grant
    Filed: March 14, 1995
    Date of Patent: June 3, 1997
    Assignee: The Regents of the University of California
    Inventors: Burt G. Feuerstein, Gayatry Mohapatra, Dong H. Kim